These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22547198)

  • 21. Analysis of proteins using DIGE and MALDI mass spectrometry.
    Winnik WM; Dekroon RM; Jeong JS; Mocanu M; Robinette JB; Osorio C; Dicheva NN; Hamlett E; Alzate O
    Methods Mol Biol; 2012; 854():47-66. PubMed ID: 22311753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2D-difference gel electrophoretic proteomic analysis of a cell culture model of alveolar rhabdomyosarcoma.
    Pressey JG; Pressey CS; Robinson G; Herring R; Wilson L; Kelly DR; Kim H
    J Proteome Res; 2011 Feb; 10(2):624-36. PubMed ID: 21110518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA as potential biomarkers in Glioblastoma.
    Areeb Z; Stylli SS; Koldej R; Ritchie DS; Siegal T; Morokoff AP; Kaye AH; Luwor RB
    J Neurooncol; 2015 Nov; 125(2):237-48. PubMed ID: 26391593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histology-based expression profiling yields novel prognostic markers in human glioblastoma.
    Dong S; Nutt CL; Betensky RA; Stemmer-Rachamimov AO; Denko NC; Ligon KL; Rowitch DH; Louis DN
    J Neuropathol Exp Neurol; 2005 Nov; 64(11):948-55. PubMed ID: 16254489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics.
    Heroux MS; Chesnik MA; Halligan BD; Al-Gizawiy M; Connelly JM; Mueller WM; Rand SD; Cochran EJ; LaViolette PS; Malkin MG; Schmainda KM; Mirza SP
    Physiol Genomics; 2014 Jul; 46(13):467-81. PubMed ID: 24803679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach.
    Collet B; Guitton N; Saïkali S; Avril T; Pineau C; Hamlat A; Mosser J; Quillien V
    Proteome Sci; 2011 Apr; 9(1):16. PubMed ID: 21470419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid 2D DIGE Proteomic Analysis of Mouse Liver.
    Kamata S; Ishii I
    Methods Mol Biol; 2018; 1664():153-166. PubMed ID: 29019132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic markers for glioblastoma.
    Jung CS; Unterberg AW; Hartmann C
    Histol Histopathol; 2011 Oct; 26(10):1327-41. PubMed ID: 21870336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
    Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
    OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance.
    Hallal S; Russell BP; Wei H; Lee MYT; Toon CW; Sy J; Shivalingam B; Buckland ME; Kaufman KL
    Proteomics; 2019 Jan; 19(1-2):e1800157. PubMed ID: 30451371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions.
    Polisetty RV; Gautam P; Sharma R; Harsha HC; Nair SC; Gupta MK; Uppin MS; Challa S; Puligopu AK; Ankathi P; Purohit AK; Chandak GR; Pandey A; Sirdeshmukh R
    Mol Cell Proteomics; 2012 Jun; 11(6):M111.013565. PubMed ID: 22219345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic level changes associated with S3I201 treated U87 glioma cells.
    Jain R; Atak A; Yeola A; Srivastava S
    J Proteomics; 2017 Jan; 150():341-350. PubMed ID: 27565396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multifarious proteomic signatures and regional heterogeneity in glioblastomas.
    Park CK; Jung JH; Park SH; Jung HW; Cho BK
    J Neurooncol; 2009 Aug; 94(1):31-9. PubMed ID: 19219580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative proteomics reveals the novel co-expression signatures in early brain development for prognosis of glioblastoma multiforme.
    Yu X; Feng L; Liu D; Zhang L; Wu B; Jiang W; Han Z; Cheng S
    Oncotarget; 2016 Mar; 7(12):14161-71. PubMed ID: 26895104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers.
    Jovčevska I; Zupanec N; Kočevar N; Cesselli D; Podergajs N; Stokin CL; Myers MP; Muyldermans S; Ghassabeh GH; Motaln H; Ruaro ME; Bourkoula E; Turnšek TL; Komel R
    PLoS One; 2014; 9(11):e113688. PubMed ID: 25419715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular classification and survival prediction in human gliomas based on proteome analysis.
    Iwadate Y; Sakaida T; Hiwasa T; Nagai Y; Ishikura H; Takiguchi M; Yamaura A
    Cancer Res; 2004 Apr; 64(7):2496-501. PubMed ID: 15059904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic Analysis of Brain Tissue from a Chronic Model of Stress Using a Combined 2D Gel Electrophoresis and Mass Spectrometry Approach.
    Guest PC
    Methods Mol Biol; 2020; 2138():391-406. PubMed ID: 32219766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.